help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ergul, A.
Right arrow Articles by Puett, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ergul, A.
Right arrow Articles by Puett, D.

Endocrinology, Vol 132, 598-603, Copyright © 1993 by Endocrine Society


ARTICLES

Endothelin-1 promotes steroidogenesis and stimulates protooncogene expression in transformed murine Leydig cells

A Ergul, MK Glassberg, MH Majercik and D Puett
Department of Biochemistry, University of Miami School of Medicine, Florida 33101.

The effects of endothelin-1 (ET-1), a potent vasoconstrictor and mitogen to various cell types, on proliferation and differentiated functions of the murine Leydig tumor cell line MA-10 were investigated. Kinetic binding experiments at room temperature showed that [125I] ET-1 bound to MA-10 cells and reached equilibrium in 2 h. The data from competitive binding experiments yielded an apparent single class of high affinity binding sites characterized by a Kd and maximum binding capacity of 1 nM and 59 fmol/10(6) cells, respectively. For steroidogenic assays, cells were incubated with ET-1 (1 pM to 1 microM) and with epidermal growth factor (10 ng/ml) for 4 h at 37 C, and the progesterone levels in the medium were measured by RIA. Like epidermal growth factor, ET-1 caused about a 6-fold increase in progesterone production. ET-1 also enhanced the transient expression of the protooncogenes c-jun and c-myc by 3- and 2-fold, respectively. For proliferation studies, ET-1 (1 pM to 1 microM) was added to quiescent MA-10 cells for 24 h, and cell counts were performed; no increase in cell number was observed. The results of this study demonstrate that MA- 10 cells possess high affinity binding sites for ET-1 and that ET-1 stimulates progesterone production and protooncogene expression, but not mitosis in this cell line.


This article has been cited by other articles:


Home page
Biol. Reprod.Home page
M. D. Doerr, M. P. Goravanahally, J. D. Rhinehart, E. K. Inskeep, and J. A. Flores
Effects of Endothelin Receptor Type-A and Type-B Antagonists on Prostaglandin F2alpha-Induced Luteolysis of the Sheep Corpus Luteum
Biol Reprod, April 1, 2008; 78(4): 688 - 696.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. J Johnson, J. B Hensley, M. D Kelso, D. G Wallace, and K. W Gaido
Mapping Gene Expression Changes in the Fetal Rat Testis Following Acute Dibutyl Phthalate Exposure Defines a Complex Temporal Cascade of Responding Cell Types
Biol Reprod, December 1, 2007; 77(6): 978 - 989.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. N. Pandey, P. M. Oliver, N. Maeda, and O. Smithies
Hypertension Associated with Decreased Testosterone Levels in Natriuretic Peptide Receptor-A Gene-Knockout and Gene-Duplicated Mutant Mouse Models
Endocrinology, November 1, 1999; 140(11): 5112 - 5119.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
L. Gnessi, A. Fabbri, and G. Spera
Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment
Endocr. Rev., August 1, 1997; 18(4): 541 - 609.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society